• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Glaucoma  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

Dr Weene is concerned that the subtitle of our paper is "sensational." We believe that the subtitle is simply descriptive of the results; medical treatment does delay or prevent the onset of primary open-angle glaucoma in individuals with ocular hypertension.¹ We agree with Dr Weene that these results do not imply that all ocular hypertensive individuals should receive treatment. It is clear that many ocular hypertensive patients are at very low risk for developing primary open-angle glaucoma and are probably not good candidates for such treatment. In Kass et al¹ and its companion article,² we emphasize that treatment should be considered in moderate- to high-risk ocular hypertensive patients, taking into consideration other factors, such as age, general health, and life expectancy. All clinicians have the responsibility of educating patients so that they and their doctors can make informed decisions.

Michael A. Kass, MD; Mae O. Gordon, PhD
St . . . [Full Text of this Article]

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Ocular Hypertension Treatment Study Results Could Be Misconstrued
Lawrence E. Weene
Arch Ophthalmol. 2003;121(7):1070.
EXTRACT | FULL TEXT